Search results
20 cze 2024 · Klein and colleagues show that low-dose COVID-19 vaccination prevents breakthrough infection-mediated hippocampal dysfunction and cognitive memory decline in mouse models.
9 sty 2023 · One or two doses of a modified vaccinia virus Ankara (MVA) vector expressing the SARS-CoV-2 spike (S) protein (MVA-CoV2-S) conferred full protection against SARS-CoV-2 cerebral infection,...
25 cze 2024 · Neurological post-acute sequelae of COVID-19 (neuroPASC) may be prevented by vaccination against SARS-CoV-2, even when other symptoms develop (breakthrough infection). Mechanisms underlying...
11 gru 2023 · Neuromuscular diseases (NMD) emerged as one of the main side effects of the COVID-19 vaccination. We pooled and summarized the evidence on the clinical features and outcomes of NMD associated with COVID-19 vaccination.
11 paź 2024 · The study authors say their finding may indicate a way to make better COVID-19 vaccines: by altering how they present the spike surface protein of SARS-CoV-2 to a person’s immune cells. Durability is an age-old bugaboo of vaccine designers. Some vaccines, particularly ones made from weakened versions of viruses, can protect people for decades ...
The data indicated an association between Ad26.COV2.S and an increased risk of GBS (observed-to-expected [OE] ratio at 21 days, 3.79; 95% CI, 2.88-4.88; OE ratio at 42 days, 2.34; 95% CI, 1.83-2.94), which was not observed for the mRNA vaccines (OE ratio less than 1 for both mRNA vaccines).11.
1 lut 2024 · Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively susceptible and permissive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
